Conference Recap
Conference Recap
Advances in Diabetes and Heart Disease From ESC 2022
The mortality risk of diabetes, the consistent efficacy of dapagliflozin, and adherence to SGLT2...
Conference Recap
Diabetes and Heart Disease Highlights From ACC 2022
Dr Martha Gulati shares key reports from ACC 2022, including updates on SGLT2 inhibitors from the SCORED trial, chronic hypertension in pregnancy...
Conference Recap
Heart Failure Highlights From AHA 2021
Key heart failure abstracts from AHA 2021 include efficacy and qualify-of-life data on empagliflozin, symptom improvement using canagliflozin, and...